Ayşe Ercan
Impact in
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
- Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
Papers in
-
- Metabolomics and Mass Spectrometry Studies 3
-
- Cancer, Lipids, and Metabolism 4
- Co-authors
- Meltem Müftüoğlu (3 shared papers)Mutlu Dilsiz Aytemir (4 shared papers)Özlem Dalmızrak (3 shared papers)Gülberk Uçar (4 shared papers)Turgay Dalkara (1 shared paper)Bülent Elibol (1 shared paper)Barij Nayan Sinha (2 shared papers)Venkatesan Jayaprakash (2 shared papers)
In The Last Decade
Ayşe Ercan
29 papers receiving 630 citations
Peers
Comparison fields: 5 of 100
- Neurology 131
- Neurology 44
- Organic Chemistry 153
- Pharmaceutical Science 30
- Toxicology 15
Countries citing papers authored by Ayşe Ercan
This map shows the geographic impact of Ayşe Ercan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayşe Ercan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayşe Ercan more than expected).
Fields of papers citing papers by Ayşe Ercan
This network shows the impact of papers produced by Ayşe Ercan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayşe Ercan. The network helps show where Ayşe Ercan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ayşe Ercan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 181 | |
| 2 | 2019 | 63 | |
| 3 | 2008 | 54 | |
| 4 | 2014 | 43 | |
| 5 | 2011 | 38 | |
| 6 | 2009 | 33 | |
| 7 | 2018 | 32 | |
| 8 | 2016 | 28 | |
| 9 | 1999 | 20 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 16 | |
| 12 | 2013 | 14 | |
| 13 | 2017 | 14 | |
| 14 | 2019 | 13 | |
| 15 | 2019 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2019 | 8 | |
| 18 | 2020 | 7 | |
| 19 | 2020 | 7 | |
| 20 | 2018 | 6 |
About Ayşe Ercan
Ayşe Ercan is a scholar working on Molecular Biology, Cancer Research, Organic Chemistry, Oncology and Biomaterials, having authored 29 papers that have together received 641 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (4 papers), melanin and skin pigmentation (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), Hemostasis and retained surgical items (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Neurology (131 citations), Neurology (44 citations), Organic Chemistry (153 citations), Pharmaceutical Science (30 citations) and Toxicology (15 citations). Ayşe Ercan has collaborated with scholars based in Türkiye, Iran and India. Frequent co-authors include Meltem Müftüoğlu, Mutlu Dilsiz Aytemir, Özlem Dalmızrak, Gülberk Uçar, Turgay Dalkara, Bülent Elibol, Barij Nayan Sinha, Venkatesan Jayaprakash, Erem Bilensoy and Gamze Varan. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, International Journal of Pharmaceutics, Bioorganic Chemistry, Anti-Cancer Agents in Medicinal Chemistry and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.